Language:

Novel Risk Markers and Risk Assessments for Cardiovascular Disease

Circulation research, 2017-01, Vol.120 (1), p.133-149 [Peer Reviewed Journal]

2017 American Heart Association, Inc. ;Copyright Lippincott Williams & Wilkins Ovid Technologies Jan 6, 2017 ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.116.309955 ;PMID: 28057790

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
Author: Thomas, Mark R ; Lip, Gregory Y.H
Subjects: Animals ; Arteriosclerosis ; Biomarkers - blood ; Calcium-binding protein ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - genetics ; Coronary artery ; Coronary artery disease ; Fibrillation ; Fibrosis ; Health risk assessment ; Heart diseases ; Humans ; Inflammation Mediators - blood ; MicroRNAs - blood ; MicroRNAs - genetics ; Pain ; Precision medicine ; Ribonucleic acid ; Risk assessment ; Risk Assessment - methods ; Risk Factors ; RNA ; Thrombosis ; Troponin
Is Part Of: Circulation research, 2017-01, Vol.120 (1), p.133-149
Description: The use of risk markers has transformed cardiovascular medicine, exemplified by the routine assessment of troponin, for both diagnosis and assessment of prognosis in patients with chest pain. Clinical risk factors form the basis for risk assessment of cardiovascular disease and the addition of biochemical, cellular, and imaging parameters offers further refinement. Identifying novel risk factors may allow greater risk stratification and a steady, but gradual progression toward precision medicine. Indeed, the generation of data in this area of research is explosive and when combined with new technologies and techniques provides the potential for more refined, targeted approaches to cardiovascular medicine. Although discussing the most recent developments in this field, this review article aims to strike a balance between novelty and validity by focusing on recent large sample-size studies that have been validated in a separate cohort in most cases. Risk markers related to atherosclerosis, thrombosis, inflammation, cardiac injury, and fibrosis are introduced in the context of their pathophysiology. Rapidly developing new areas, such as assessment of micro-RNA, are also explored. Subsequently the prognostic ability of these risk markers in coronary artery disease, heart failure, and atrial fibrillation is discussed in detail.
Publisher: United States: American Heart Association, Inc
Language: English
Identifier: ISSN: 0009-7330
EISSN: 1524-4571
DOI: 10.1161/CIRCRESAHA.116.309955
PMID: 28057790
Source: GFMER Free Medical Journals
MEDLINE

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Novel Risk Markers and Risk Assessments for Cardiovascular Disease

2017 American Heart Association, Inc. ;Copyright Lippincott Williams & Wilkins Ovid Technologies Jan 6, 2017 ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.116.309955 ;PMID: 28057790

Searching Remote Databases, Please Wait